Circulating procoagulant microparticles and soluble GPV in myocardial infarction treated by primary percutaneous transluminal coronary angioplasty. A possible role for GPIIb-IIIa antagonists
O. Morel, B. Hugel, L. Jesel, Z. Mallat, F. Lanza, M-P. Douchet, M. Zupan, M. Chauvin, J-P. Cazenave, A. Tedgui, J-M. Freyssinet, F. TotiVolume:
2
Year:
2004
Language:
english
Pages:
9
DOI:
10.1111/j.1538-7836.2004.00805.x
File:
PDF, 348 KB
english, 2004